technetium tc 99m sestamibi has been researched along with Fibrocartilaginous Dysplasia of Bone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aras, M; Dede, F; Erdil, TY; Erol, B; Inanir, S; Ones, T; Turoglu, HT | 1 |
| Jung, DS; Kim, DS; Kim, IJ; Kim, SJ; Kim, YK; Seok, JW | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Fibrocartilaginous Dysplasia of Bone
| Article | Year |
|---|---|
The role of dual-phase Tc-99m MIBI in the evaluation of potentially operable lesions detected by bone scanning in fibrous dysplasia: a long-term prospective follow-up study.
Topics: Adult; Aged; Child; Female; Fibrous Dysplasia of Bone; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Whole Body Imaging | 2012 |
Fibrous dysplasia associated with primary hyperparathyroidism in the absence of the McCune-Albright syndrome: Tc-99m MIBI and Tc-99m MDP findings.
Topics: Adult; Diagnosis, Differential; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Humans; Hyperparathyroidism; Male; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Whole-Body Counting | 2003 |